SCHEMBL17942005

SCHEMBL17942005

CCOc1c(F)c(=O)[nH]c2cc(Br)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ GRIN2D O15399 1/20 0.40
▸ GRIN3B O60391 1/20 0.40
▸ GRIN1 Q05586 1/20 0.40
▸ GRIN2A Q12879 1/20 0.40
▸ GRIN2B Q13224 1/20 0.40
▸ GRIN2C Q14957 1/20 0.40
▸ GRIN3A Q8TCU5 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ PARP1 P09874 2/20 0.39
▸ PARP3 Q9Y6F1 2/20 0.39
▸ PARP2 Q9UGN5 1/20 0.39
▸ CDK4 P11802 2/20 0.38
▸ CCND1 P24385 2/20 0.38
▸ EGFR P00533 1/20 0.38
▸ CDK2 P24941 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25986282 0.84 CDK4 (0.44) METAP2GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL17941937 0.78 PARP1 (0.59) HSD17B10PARP1
SCHEMBL25738484 0.73 METAP2 (0.47) METAP2MAPTPARP1CDK4CCND1
SCHEMBL17941961 0.73 METAP2 (0.47) METAP2MAPTGRIN2DGRIN3BGRIN1
SCHEMBL31212369 0.73 METAP2 (0.47) METAP2MAPTGRIN2DGRIN3BGRIN1
SCHEMBL16651204 0.72 GSK3B (0.47) MAPTESR2HSD17B10CA12CA9
SCHEMBL28127116 0.69 CHRNB2 (0.44) METAP2CDK4CCND1CHRNB2CHRNA7
SCHEMBL20535547 0.69 ALOX15 (0.50) MAPT
SCHEMBL8162707 0.68 RAB9A (0.48) METAP2MAPTESR2HSD17B10CHRNB2
SCHEMBL31422791 0.68 GABRA1 (0.49) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3247705-B1 QUINAZOLINE AND QUINOLINE COMPOUNDS AND USES THEREOF AS NAMPT INHIBITORS MILLENNIUM PHARM INC (US) 2019-11-20 — — EP disclosed
EP-3247705-A1 QUINAZOLINE AND QUINOLINE COMPOUNDS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2017-11-29 — — EP disclosed
WO-2016118565-A1 QUINAZOLINE AND QUINOLINE COMPOUNDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-07-28 — — WO disclosed
WO-2016118565-A1 QUINAZOLINE AND QUINOLINE COMPOUNDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2016-07-28 — — WO disclosed
Send feedback